STOCK TITAN

Novo Nordisk A/S (NVO) Revenue by Year

NVO NYSE

Novo Nordisk A/S generated $48.6B in revenue in fiscal year 2025. This represents an increase of 20.5% from the prior fiscal year. The table below carries 11 fiscal years, from 2015 to 2025, and the quarters Novo Nordisk A/S has filed alongside them.

FY2025 annual
Revenue $48.6B
YoY +20.5%
5Y CAGR +18.4%
10Y CAGR +12.0%
Source SEC Filings (20-F/6-K) Latest period FY2025, ended Dec 31, 2025 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

NVO Revenue by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2520-FFY2420-FFY2320-FFY2220-FFY2120-FFY2020-FFY1920-FFY1820-FFY1720-FFY1620-FFY1520-F
Revenue$48.6B+20.5%$40.3B+16.9%$34.5B+35.4%$25.5B+18.8%$21.4B+2.7%$20.9B+13.8%$18.3B+6.8%$17.2B-4.9%$18.0B+13.7%$15.9B+1.0%$15.7B

NVO Revenue by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ4'2520-FQ4'2420-FQ4'2320-FQ4'2220-FQ4'2120-FQ4'2020-FQ4'1920-FQ4'1820-FQ4'1720-FQ4'1620-FQ4'1520-F
RevenueN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A

What revenue means

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.

More Novo Nordisk A/S financials

Frequently Asked Questions

What was Novo Nordisk A/S's revenue in fiscal year 2025?

Novo Nordisk A/S generated $48.6B in revenue in fiscal year 2025.

How fast is Novo Nordisk A/S's revenue growing?

Novo Nordisk A/S (NVO) revenue rose by 20.5% year over year, from $40.3B to $48.6B in fiscal year 2025.

How has Novo Nordisk A/S's revenue changed over the years?

Across the 11 fiscal years this page covers, Novo Nordisk A/S (NVO) revenue went from $15.7B in fiscal year 2015 to $48.6B in fiscal year 2025.

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Novo Nordisk A/S (NVO) reported on that line in every period on record.